/
Theme 4: Commercializing Theme 4: Commercializing

Theme 4: Commercializing - PowerPoint Presentation

kaptainpositive
kaptainpositive . @kaptainpositive
Follow
342 views
Uploaded On 2020-06-30

Theme 4: Commercializing - PPT Presentation

Aflasafe as a biocontrol for aflatoxins Project Review 27 th September 2018 40 of Zambian children not getting the best start in life Very low weight for height amp severe muscle wasting ID: 790012

amp aflasafe food efficacy aflasafe amp efficacy food registration complementary awareness aflatoxin product market foods seed development 2015 evidence

Share:

Link:

Embed:

Download Presentation from below link

Download The PPT/PDF document "Theme 4: Commercializing" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Theme 4: Commercializing Aflasafe as a biocontrol for aflatoxinsProject Review: 27th September, 2018

Slide2

40% of Zambian children not getting the best start in life!(Very low weight for height & severe muscle wasting)

Facts form ZDHS 2014)9% born underweight (<2.5 kg)60% are anemic

Stunting rate: 40%Micronutrient deficiencies very common

Nutritional status of babies aged 6-24 months

Slide3

Complementary food type

Food type

Proportion (%) of children fed

Chibwantu

drink

3.2

Groundnut relish

1.8

Nshima

66.4

Porridge

21.5

Samp7.1

Various types of foods administered to children on case by case basis, from 0 month.

Main challenge: maize-based foods with minimal dietary diversification

Slide4

Nutritional composition of complementary foods

Parameter

Mean (g/100g) for

Chipata

district (

N=60)

Mean (g/100g) for

Monz

e district (

N=41)

Moisture content

78.8±4.

8a82.5±1.5aDry matter21.2±4.8a17.5±1.5aAsh0.4±0.3a0.2±0.1b

F

at

0.2±0.1a0.3±0.2aProtein2±0.8a2.2±0.1aSugar1±0.6a0.1±0.1bStarch21.5±4.0a16±0.3bTotal carbohydrate18.7±4.7a14.8±1.3b

Traditional complementary foods low in fat & protein contents

Recommended daily intake: Protein: 0.8g/

kgbw

; Fat is 44-78g

Slide5

Complementary food quality

Complementary food quality compromised by presence of aflatoxin

Food type

Max

Mean

Proportion of complementary food (%)

<4ppb

5-10ppb

11-20ppb

>20ppb

Unsafe for babies, >2ppb

Chibwantu

7.02.190.99.10.00.018.2Gnut relish98.02150.016.716.716.750.0Nshima34.0392.02.72.72.718.2Porridge104.05.393.10.04.24.2

27.8

Samp

500.030.683.38.30.04.225.0Aflatoxin has negative impact on health-may retard growth

Slide6

Main activities

Aflatoxin surveillance: microbial & chemical analyses

Capacity building

Awareness creation

Aflasafe Product developmentAflasafe

efficacy & registration for commercial use

Improving food safety, public health & income through aflatoxin mitigation

FTF INITIATIVE: 2011-2015

Slide7

Limited data on

aflasafe

efficacy

Aflasafe upscaling & commercialization: focus should cover the entire country, thus necessitating evidence on efficacy in other regions

Un-registered productLack of awareness

Lack of legal framework for pesticide registration

FTF initiative: gaps as of 2015

Slide8

Assessing

Aflasafe

efficacy in Region I & III AEZ

Creating awareness Pursue full registration of

aflasafe for commercializationDevelop a business plan

Africa RISING: Going to Scale in EP of Zambia

Slide9

Approaches of taking the technologies to scale

Private sector engagement for on-farm

field trials

Extension systems (Ministry of agriculture) and community

agro

-dealers

Stakeholder consultative meetings: e.g. AATF workshop

Slide10

6 tons of

aflasafe

imported from Nigeria/ Tanzania

150 maize fields335 groundnut farms

Aflasafe

: evidence of efficacy

Slide11

< 4

< 10

< 20

> 20

EU

COMESA

USA

UNSAFE

Maximum allowable aflatoxin level (ppb

)

Aflasafe

: evidence of efficacy

Slide12

99% G 80% M 99% GN 97% M 95% GN 75% M

Aflasafe

: evidence of efficacy

Slide13

Market & demand

Market: Local processors, school feeding programs, regional traders, consumers

60% of farmers willing to pay for such a product

Potential aflasafe manufacture: Share-Africa Zambia & ZAMSEED

Companies expressed need for seed money to jump start the manufacturing processPotential distribution channels

Seed & input supplies

NGOs & development partners

Business Plan development: Feasibility assessment

Slide14

4. Awareness raising

Year

Female

Male

2015/2016

205

162

2016/2017

171

161

Slide15

Technology Transfer Agreement prepared & Signed

2 Dossiers submitted to ZEMA

Feedback provided

ZEMA Engagement

2015

Registration requirements identified

Review & Independent evaluation

ZEMA approval

Dossier

Re-submission-July 2018

Aflasafe

product registration journey

APPROVEDAugust 2018

Slide16

Market & demand

Market: Local processors, Govt school feeding programs, regional traders, consumers

60% of farmers willing to pay for such a product

Potential aflasafe manufacture: Share-Africa Zambia & ZAMSEED

Companies expressed need for seed money to jump start the manufacturing processPotential distribution channels:

Current distributer- ZARI Seed & input supplies

NGOs & development partners

Business Plan development: Feasibility assessment

Slide17

Exposure to aflatoxin is occurring but awareness is low

Solutions are available

Way forward

Effective communication strategy to increase awareness

Pursue full registration of Aflasafe

Develop aflasafe commercialization strategyPublic/ private sector driven for faster uptake and diffusion of the technology

Engage

aflasafe

interested stakeholders for limited use of the product

Sourcing funds for implementing a commercialization strategy

Aflasafe

importation: need for import license

Construction of manufacturing plant: legal requirement-an EIA Conclusion & Way forward

Slide18

Aflasafe team